Norwest Equity Partners acquires Vista's SIS software solutions

NewsGuard 100/100 Score
Surgical Information Systems, a leader in perioperative information systems, announced today that Norwest Equity Partners ("NEP"), a leading middle-market equity investment firm, has acquired the Company from Vista Equity Partners ("Vista").  The current SIS executive team, led by Ed Daihl, Chief Executive Officer, will remain in place following this investment.  Clients and associates will benefit from the resulting accelerated delivery of new, innovative software solutions.

Founded in 1996 and headquartered in Alpharetta, Georgia, SIS software solutions are uniquely designed to add value at every point in the perioperative process.  Developed specifically for the complex surgical environment, all SIS modules--including anesthesia--are built on a single database and integrate easily with other hospital systems.  Clients include leading academic and medical research centers, integrated delivery networks and hospitals of all sizes.  

"By maintaining our focus on the financial engine of the hospital, SIS has achieved year-over-year growth that significantly exceeds industry averages. We have also enjoyed success in the perioperative area during some of the most challenging economic conditions in memory," said Daihl.  "Demand for perioperative-specific information solutions is rapidly growing, particularly in anesthesia solutions, and our new partnership with NEP represents the continuing evolution of the company.  Our efforts, combined with NEP's 50 years of investment experience and access to resources, will enable SIS to continue to strategically deliver on our promise to improve perioperative safety, efficiency and profitability."

"We're excited to welcome SIS to our portfolio, and our team looks forward to partnering with management to continue the Company's significant momentum and market success," said Tim Kuehl, a Partner at NEP.  "SIS is an outstanding company and is a key part of our long-term health care and applied technology investment strategy."  In recent years, NEP has made several investments in software-based companies, such as Amcom Software, Mitchell International and Rosetta Stone.

Jim Lindner, a NEP Operating Partner with over 40 years experience in the software technology and services industry will serve as Non-Executive Chairman at the Company.  "I am thrilled with the opportunity to partner with SIS," said Lindner.  "It is a well-run company, led by an excellent management team that values its clients, offers great products and has tremendous growth momentum." 

SIS solutions are focused on the perioperative department, which accounts for up to 60 percent of hospital margin.  "Along with our new investment partner, our fundamental approach remains the same," said Daihl.  "We will continue to work closely with clients to enable them to enhance patient care while providing highly-interoperable, ONC meaningful-use certified solutions."  

"We initially invested in SIS because we saw the opportunity to bring together a talented executive team that would deliver best-in-class solutions to their clients," said Robert F. Smith, Chairman and CEO of Vista.  "It has been our pleasure to work with SIS over the last four years to deliver unmatched value to their clients and the healthcare industry as a whole.  SIS is well-positioned to continue its heritage of bringing tremendous value to perioperative healthcare at a time when U.S. hospitals need it most."  

Source:

Surgical Information Systems

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Largest genetic study of gestational diabetes discovers nine novel genetic regions linked to severe and common pregnancy complication